• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Bactolac Pharmaceutical Inc

+ Add to Watchlist


Snapshot for Bactolac Pharmaceutical Inc (BTCA)

Open: - Day's Range: - Volume: 0
Previous Close: 120,000.0000 52wk Range: 120,000.0000 - 120,000.0000 1-Yr Rtn: -

Stock Chart for BTCA

No chart data available.
  • BTCA:US 120,000.0000
  • 1M
  • 1Y
Interactive BTCA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTCA

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) 3,989.9998
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 0.01
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.17%
Cash Dividend (USD) 1,400.0000
Dividend Ex-Date 04/15/2014
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTCA

No data available

Company Profile & Key Executives for BTCA

Bactolac Pharmaceutical, Inc. formulates, manufactures, and packages nutraceuticals. The Company produces products for weight loss, sports nutrition, energy products, antioxidant, formulas designed specifically for men, women and children, stress formulas, relaxation formulas, life extension, immune enhancement, and brain, cleansing and cholesterol products and others.

Pailla M ReddyPresident/CEORenee ReynoldsChief Financial Officer
Jeffrey G McGonegalSenior VP:Finance/SecretaryAlix VilledrouinController
More Company Profile & Key Executives for BTCA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil